What is the clearance time from the body for testosterone cypionate and Anavar (oxandrolone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clearance Time for Testosterone Cypionate and Anavar

Testosterone cypionate has a half-life of approximately 8 days and is detectable in the body for roughly 2-3 months after the last injection, while Anavar (oxandrolone) clears much more rapidly, typically becoming undetectable in urine within 3-4 weeks after discontinuation.

Testosterone Cypionate Clearance

Based on FDA labeling, testosterone cypionate has an elimination half-life of approximately 8 days when injected intramuscularly 1. The drug is absorbed slowly from the lipid phase after intramuscular injection, allowing for dosing intervals of 2-4 weeks during therapeutic use 1.

Key Pharmacokinetic Details:

  • Peak levels: Occur 2-5 days after injection
  • Return to baseline: Typically 10-14 days after a single injection 2
  • Complete clearance: Given the 8-day half-life, it takes approximately 5-6 half-lives for near-complete elimination, meaning 40-48 days (roughly 6-7 weeks) for therapeutic doses
  • Detection window: In practice, testosterone metabolites and altered testosterone/epitestosterone ratios can be detected for 2-3 months after cessation, particularly with higher or repeated doses

The drug is approximately 98% protein-bound in plasma, and about 90% is excreted in urine as glucuronic and sulfuric acid conjugates 1. Metabolism occurs primarily in the liver through conversion to various 17-keto steroids 1.

Anavar (Oxandrolone) Clearance

Oxandrolone clears considerably faster than testosterone cypionate. Research demonstrates that oxandrolone and its metabolites are detectable in urine for approximately 3-4 weeks after transdermal application, with detection windows showing inter-individual variability 3.

Key Pharmacokinetic Details:

  • Detection after single dose: Can be detected within hours and for up to 10-14 days in some individuals 3
  • Typical clearance: Most individuals clear the drug within 3-4 weeks of discontinuation
  • Metabolism: Oxandrolone undergoes hepatic metabolism as a 17-alpha-alkylated androgen 4

A pharmacokinetic study showed that when oxandrolone was co-administered with warfarin, it resulted in a 5.5-fold increase in warfarin half-life, demonstrating significant metabolic interactions, though this doesn't directly indicate oxandrolone's own half-life 4.

Clinical Context and Monitoring Implications

Important Caveats:

Dose-dependent clearance: Higher doses and longer duration of use extend detection windows significantly. Supraphysiologic doses used in non-medical contexts will have longer clearance times than therapeutic doses.

Individual variability: Factors affecting clearance include:

  • Liver function (both drugs undergo hepatic metabolism)
  • Body composition and fat distribution (testosterone cypionate is lipophilic)
  • Age and metabolic rate
  • Kidney function (affects excretion of metabolites)
  • Albumin levels (affects testosterone binding and clearance) 5

Detection vs. physiologic clearance: The time until a drug is undetectable in testing may exceed the time until physiologic effects resolve. Testosterone suppression of endogenous production, for example, can persist well beyond when exogenous testosterone is cleared 5.

Monitoring Considerations:

For testosterone cypionate, guidelines recommend measuring testosterone levels midway between injections during therapeutic use 6, 7. After discontinuation, endogenous testosterone recovery is highly variable, with older age and prolonged use associated with longer recovery times 8.

For oxandrolone, liver function tests should be monitored periodically due to hepatotoxicity risk, particularly with the 17-alpha-alkylated structure 4. Hepatic dysfunction can prolong clearance times.

Practical Timeline Summary:

  • Testosterone Cypionate:

    • Therapeutic effect wanes: 10-14 days
    • Near-complete elimination: 6-8 weeks
    • Detection window: 2-3 months
  • Anavar (Oxandrolone):

    • Therapeutic effect wanes: Days to 1-2 weeks
    • Near-complete elimination: 3-4 weeks
    • Detection window: 3-4 weeks (variable)

These timelines assume therapeutic dosing; supraphysiologic doses will extend all timeframes proportionally.

Related Questions

With a serum total testosterone of 1281 ng/dL while using testosterone cypionate 100 mg/mL twice weekly, how should I adjust the dose?
What is the appropriate next lower dose of testosterone cypionate for a patient currently receiving 50 mg injections twice weekly?
In a 57-year-old male with low ferritin (20.7 ng/mL) and elevated hemoglobin (17.5 g/dL) and hematocrit (58.4 %), who is taking testosterone enanthate 200 mg intramuscularly every 5 days, how can his testosterone level be increased without further raising hemoglobin/hematocrit or decreasing ferritin?
In a 75-year-old man receiving testosterone replacement therapy (200 mg testosterone enanthate every two weeks) with free testosterone 203 pg/mL, total testosterone 889 ng/dL, and estradiol 43 pg/mL, what further workup and treatment adjustments are recommended?
In a 70-year-old man on weekly injectable testosterone (enanthate or cypionate) with a serum testosterone level of 1500 ng/dL, how should the therapy be adjusted?
In a patient with an antistreptolysin O (ASO) titer > 6400 who is currently receiving azithromycin, should the therapy be changed to a penicillin such as amoxicillin or penicillin V?
In an older woman with low anti‑Müllerian hormone (AMH) indicating poor ovarian reserve, which ovarian stimulation protocol—Pergoveris (recombinant FSH + LH), Gonal‑F (recombinant FSH) plus Rekovelle (recombinant LH), Menopur (human menopausal gonadotropin), or Humog (human menopausal gonadotropin)—is optimal?
What CPT code(s) should be used for open reduction and internal fixation of a left distal fibular fracture with syndesmotic fixation?
What are the clinical uses of N‑acetylcysteine (NAC)?
What is the appropriate rivaroxaban dosing for anticoagulation?
Can elevated total serum calcium with normal ionized calcium cause electrocardiographic changes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.